We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWW icon
1551
CALL
iShares MSCI Mexico ETF
EWW
$1.92B
$1.39M ﹤0.01%
29,600
+29,000
+4,833% +$1.5M
REI icon
1552
Ring Energy
REI
$287M
$1.38M ﹤0.01%
+1,013,280
New +$1.52M
PINC
1553
DELISTED
Premier
PINC
$1.38M ﹤0.01%
64,923
+37,196
+134% +$789K
CVEO icon
1554
Civeo
CVEO
$376M
$1.37M ﹤0.01%
60,439
-10,162
-14% -$255K
YOU icon
1555
Clear Secure
YOU
$5.43B
$1.37M ﹤0.01%
51,507
-375,906
-88% -$11.4M
PZZA icon
1556
Papa John's
PZZA
$1.02B
$1.37M ﹤0.01%
+33,401
New +$1.64M
ALGM icon
1557
Allegro MicroSystems
ALGM
$8.29B
$1.37M ﹤0.01%
+62,737
New +$1.34M
CXDO icon
1558
Crexendo
CXDO
$223M
$1.37M ﹤0.01%
262,029
-30,095
-10% -$159K
BEAM icon
1559
Beam Therapeutics
BEAM
$2.7B
$1.36M ﹤0.01%
+55,000
New +$1.4M
WASH icon
1560
Washington Trust Bancorp
WASH
$754M
$1.36M ﹤0.01%
+43,505
New +$1.51M
PFLT icon
1561
PennantPark Floating Rate Capital
PFLT
$705M
$1.36M ﹤0.01%
124,751
-493,376
-80% -$5.53M
UWMC icon
1562
UWM Holdings
UWMC
$631M
$1.36M ﹤0.01%
232,259
+170,055
+273% +$1.11M
CMRE icon
1563
Costamare
CMRE
$1.86B
$1.36M ﹤0.01%
105,460
-48,557
-32% -$668K
OPK icon
1564
Opko Health
OPK
$1.25B
$1.35M ﹤0.01%
921,487
+825,143
+856% +$1.26M
KW
1565
DELISTED
Kennedy-Wilson Holdings
KW
$1.35M ﹤0.01%
135,528
-84,617
-38% -$924K
RHI icon
1566
Robert Half
RHI
$4.04B
$1.34M ﹤0.01%
19,087
-335,419
-95% -$23.9M
TBRG
1567
DELISTED
TruBridge
TBRG
$1.34M ﹤0.01%
67,855
+11,962
+21% +$184K
NTNX icon
1568
Nutanix
NTNX
$16B
$1.33M ﹤0.01%
21,804
-114,073
-84% -$7.46M
HP icon
1569
Helmerich & Payne
HP
$3.31B
$1.33M ﹤0.01%
41,517
-24,720
-37% -$839K
VRNA
1570
DELISTED
Verona Pharma
VRNA
$1.33M ﹤0.01%
28,617
+15,805
+123% +$593K
WNS
1571
DELISTED
WNS Holdings
WNS
$1.33M ﹤0.01%
+28,021
New +$1.38M
KMT icon
1572
Kennametal
KMT
$2.71B
$1.32M ﹤0.01%
55,054
-204,690
-79% -$5.45M
GABC icon
1573
German American Bancorp
GABC
$1.92B
$1.32M ﹤0.01%
32,843
-491
-1% -$20.8K
CXT icon
1574
Crane NXT
CXT
$3.14B
$1.32M ﹤0.01%
22,603
+18,703
+480% +$1.07M
GPRE icon
1575
Green Plains
GPRE
$1.15B
$1.32M ﹤0.01%
138,714
+56,614
+69% +$638K

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.